Biomedical, Clinical & Life Sciences

No applicats  // Limit: 1 // Tickets Available: 1

DOL will consider only one application from each organization.

Under this Funding Opportunity Announcement (FOA), DOL will award grants through a competitive process to organizations providing pre-apprenticeship services that support education, occupational skills training, and employment services to opportunity youth, ages 16 to 24, while performing meaningful work and service to their communities. The YouthBuild program model prepares participants for quality jobs in a variety of careers, in diverse industry sectors, particularly in infrastructure sectors, and includes wrap-around services such as mentoring, trauma-informed care, personal counseling, transportation supports, and employment preparation - all key strategies for addressing violence in communities. YouthBuild applicants must include construction skills training and may include occupational skills training in other indemand industries. This expansion into additional in-demand industries is the Construction Plus component 

No applicants   // Limit: 1 // Tickets Available: 1 

Only one application per institution (normally identified by having a unique NIH Institutional Profile Number, IPF) is allowed.

The goal of the Medical Scientist Training Program (MSTP) is to develop a diverse pool of highly trained clinician-scientist leaders available to meet the Nation’s biomedical research needs. Specifically, this fundingopportunity announcement (FOA) provides support to eligible domestic institutions to develop and implement effective, evidence-informed approaches to integrated dual-degree training leading to the award of both clinical degrees, e.g., M.D., D.O., D.V.M., D.D.S., Pharm.D., and research doctorate degrees (Ph.D.). With the dual qualification of rigorous scientific research and clinical practice, graduates will be equipped with the skills to develop research programs that accelerate the translation of research advances to the understanding, detection, treatment and prevention of human disease, and to lead the advancement of biomedical research. Areas of particular importance to NIGMS are the iterative optimization of MSTP training efficacy and efficiency, fostering the persistence of MSTP alumni in research careers, and enhancing the diversity of the clinician-scientist workforce. NIGMS expects that the proposed research training programs will incorporate didactic, research, mentoring and career development elements to prepare trainees for careers that will have a significant impact on the health-related research needs of the Nation.
 

No applicants // Limit: 1 // Tickets Available: 1

HRSA will only review the last validated application before the Grants.gov due date.

The Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB) is accepting applications for the fiscal year (FY) 2024 Ryan White HIV/AIDS Program (RWHAP) Implementation for HIV Clinical QualityImprovement program. The purpose of this program is to provide RWHAP Part A through D recipients with training and technical assistance (T/TA) to implement quality improvement methodologies and concepts with an emphasis on skills development and implementing sustainable quality improvement activities for RWHAP Part A through D recipients with little or no experience in quality improvement. The activities outlined in this Notice of Funding Opportunity (NOFO) align with the Ryan White HIV/AIDS Program statute and HRSA HAB Clinical Quality Management (CQM) Policy Clarification Notice 15-02 (PCN 15-02). Specifically, PCN 15-02 clarifies that CQM programs consist of three components: infrastructure, performance measurement, and quality improvement. This cooperative agreement will address the quality improvement component. 

No applicants // Limit: 1 // Tickets Available: 1

Only one application per institution (normally identified by its UEI number) is allowed.

The purpose of this NOFO is to support comparative effectiveness trials to investigate the feasibility, effectiveness, and cost-effectiveness of telehealth-based interventions to detect and manage glaucoma among high-risk populations. This NOFO aims to support the study of replicable and scalable interventions that use real-world, payer-provider reimbursement structures within community-based, health care delivery settings in various regions of the United States. Outcomes should be relevant to clinical practice, public health, community implementation, and policy. This NOFO also supports the cost-effectiveness analyses of proposed interventions. The resulting data will assist policymakers, clinicians, and patients make informed decisions to reduce the burden of glaucoma and improve the quality of life for millions of people.

This NOFO will be accomplished through two components, Component A: Comparative effectiveness trials among high-risk populations within community-based settings, and Component B: a coordinating center to provide scientific and logistical support to Component A studies. 

Component A: Number of Awards: four (4); Estimated Funding: $2,750,000
Component B: Coordinating Center Number of Awards: One (1); Estimated Funding: $250,000

No Applicants // Limit: 1 // Tickets Available: 1

Only one application per institution (normally identified by having a unique entity identifier [UEI] number) is allowed. 

This Notice of Funding Opportunity (NOFO) is designed to understand the feasibility and acceptability of providing long-acting injectable antiretroviral therapy (LAI-ART) to incarcerated persons with HIV who are soon to be released from state prison facilities. The ultimate goal is to support the development and implementation of effective, sustainable, replicable LAI-ART programs. People with HIV living in prison facilities are often released to the community lacking support for ongoing HIV care. There is a paucity of programs for this population demonstrating effectiveness with retention in care and maintaining sustained HIV viral suppression after release. The use of LAI-ART prior to and at the time of release from prison may improve adherence to HIV treatment, retention in care, and maintenance of viral load suppression among persons reentering the community. Applied qualitative and quantitative research resulting from this funding is expected to strengthen adherence to ART and is aligned with the HIV National Strategic Plan (2022-2025) and the Ending the HIV Epidemic in the U.S. (EHE) initiative “Treat” Pillar.

Limit: 2 // Tickets Available: 1

 H-J. Kim (Civil Engineering)

Institutions can receive only two awards each year and can submit a limit of two applications per year.
*The ORAU Innovation Partnerships Grant Program is a single fiscal year award for events held between September 1, 2023 and September 30, 2024.

Event or conference sponsorship is often beneficial to the Oak Ridge Associated Universities (ORAU) Council of Sponsoring Institution Members, whether as a means of fostering collaboration among Council members, gaining new and important information for a proposal or business plan, and more. Up to $4,000 may be requested to support an in-person or virtual event that involves participants from more than one ORAU member institution, including students. Innovation Partnership applications should focus on focused workshops/conferences that highlight your university’s strategic STEM research and education growth areas, and where collaborations with other member universities would add value. We are specifically interested in events that can bring more thought leadership in building a national strategy for STEM education and workforce development. Member universities are encouraged to collaborate around this topic in anticipation of federal funding initiatives. 

FY 2024 Innovation Partnerships Grant Focus Areas:

• Climate and Environment - sustainability, environmental justice, clean energy, resilience to climate hazards, emerging technologies, measurement and impact assessment, diversity and inclusion, policy, and data science and analytics
• Health Equity - telemedicine, telehealth, health literacy, health communication, behavioral and mental health, health disparities, diversity and inclusion, policy, and data science and analytics
• Future of the STEM Workforce - new ways of teaching and learning (K-16), transformative workforce capacity building and mentoring, diversity and inclusion, policy, data science, machine learning, and artificial intelligence

No Applicants  // Limit:1  // Tickets Available: 1

No pre-proposals were received in the internal competition.

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research. 

To accomplish the stated over-arching goal, this NOFO will support educational activities with a primary focus on: 

• Courses for Skills Development
• Research Experiences
• Mentoring Activities

 Limit: 1 // PIs: B. Eckert & D. Axon (College of Pharmacy)

In general, multiple applications associated with the same DUNS number and/or Employee Identification Number (EIN) are not allowable. However, HRSA recognizes a growing trend towards greater consolidation within the rural health care industry and the possibility that multiple health care organizations may share the same EIN as its parent organization. 

The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2024 Rural Health Network Development Planning Program. The purpose of this program is to promote the planning and development of integrated health care networks to address the following legislative aims: (i) achieve efficiencies; (ii) expand access to, coordinate, and improve the quality of basic health care services and associated health outcomes; and (iii) strengthen the rural health care system as a whole. 

No Applicants // Limit: 1 // Tickets Available: 1 

The foundation will consider more than one application per institution per year, but only one application per laboratory/mentor per year.

The Lalor Foundation postdoctoral fellowship program supports promising new researchers in establishing scientific and teaching careers. The program’s mission is to support these researchers early in their work so that they can become independently funded in the field of mammalian reproductive biology as related to the regulation of fertility. The Lalor Foundation will award fellows $55,000 per year to cover a fellowship stipend, fringes, and institutional overhead. Other expenses are not allowed. Institutional overhead may not exceed 10 percent of the total fellowship award. Renewal for one additional year is possible; please refer to specific renewal information under Application Instructions. 

 Limit: 4 //

M. Verhougstraete (Community, Environment & Policy)
J. Schroeder (Molecular and Cellular Biology)
H. Cai (Neuroscience)
J. Bibb (Translational Neurosciences)
 

The mission of The G. Harold and Leila Y. Mathers Foundation is to advance knowledge in the life sciences by sponsoring scientific research that will benefit mankind. The foundation’s grants program seeks to support basic science, ideally with potential translational applications. Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience, etc., are some noteworthy examples of current research support. 

For many years the Foundation has enjoyed special recognition in the research community for supporting “basic” scientific research, realizing that true transformative breakthroughs usually occur after a thorough understanding of the fundamental mechanisms underlying natural phenomena. More recently, and with the advent of newer investigative methodologies, technology, and tools, the Foundation now embraces innovative translational research proposals.

The grant duration must be three years. The budget should be reasonable based on the aims of the project. Indirect costs may not exceed 10%. Preliminary Budgets are required during the LOI phase. A detailed budget justification is not required until the proposal phase.  The Foundation’s grant award is not intended to be utilized for purchasing capital equipment (“bricks-and-mortar”) for the lab and is intended only to support the actual investigation. The Foundation assumes and expects that capital equipment must be provided by the research institution or university.
 

Application Guidance:

• Grant budgets cannot exceed $600-750K 
• The Foundation primarily supports basic science, ideally with potential translational applications.
• Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience, etc., are some noteworthy examples of current research support.
• Covid-19-related research projects (aims or sub-aims) will not be considered for support.
• Medical imaging technology-related projects and/or electrical engineering technology development projects will not be considered for support.
• Plant Biology Research, Oceanography, Space Exploration. and Global warming-related research will not be considered for support.
• As technology continues to advance, it is apparent that investigations in the area of basic science and translational research may become more and more reliant on collaborative, interdisciplinary projects. It is important to note that any interdisciplinary project proposals may require additional information regarding the collaborator(s)’ achievements and relevant expertise.
• Feedback for declined LOI Requests will not be provided; LOIs or Formal Proposals that have been declined should not be resubmitted at a later date for consideration.
• Renewal applications for the same or related research will not be accorded priority consideration. It is strongly advised that any re-application for grant renewal consider a new direction based on prior research or emphasize some new potential translational aspects and not merely an extension of previously funded research.
• Requests for funding previously federally supported research and/or applications pending federal approval will not be accorded priority consideration.
• Requests for support of clinical trials or drug discovery will not be approved. The Foundation will not support projects which we consider pre-clinical drug development.